China / Boehringer Ingelheim's Stroke Rehab Centre Success & Continuing China Push
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
Top Stories
Singapore / Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading biopharmaceutical hubs and a magnet for top talent. Multitudes of biopharma and…
Turkey / The Impact Of Brexit On CE Certificates Issued By UK Notified Bodies
The shockwaves from the UK’s exit from the European Union have resounded across the continent, including in…
France / Valneva: Small, but Poised for COVID-19 Vaccine Success
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
Switzerland / A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC)…
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
France / Top 10 Pharma Companies
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and…
In Conversation
Sanjay Prabhakaran – President, Asia Pacific, Hologic
Medtech industry veteran Sanjay Prabhakaran outlines the footprint and strategy of women’s health specialist Hologic in the dynamic Asia-Pacific region, how it leveraged its molecular diagnostics expertise to pivot towards COVID-19 diagnostics tests in 2020, and the leadership lessons he has learned from a 30-year corporate career with US multinationals. Governments are now gearing up to the reality that…
Latest Reports
Focus on USA
USA: 2 Things the Biden Administration can do Now to Lower…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can…
5 US Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage…
Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and…
US FDA Drug Approvals 2020
In 2020, the US FDA's Center for Drug Evaluation & Research (CDER) approved…
Read more: USA >>
Focus on China
China: AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics…
The latest from Chinese pharma, including a new deal between AstraZeneca and…
Public Insurance Coverage for Rare Disease Patients in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
Boehringer Ingelheim’s Stroke Rehab Centre Success…
In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas…
New Drug Approvals in China 2020
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals…
Read more: China >>
Focus on Switzerland
Swiss Pharma: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland…
Building a Health Data Ecosystem in Switzerland
Although Switzerland is ahead of many of its competitors in Europe on levels of…
Swissmedic New Drug Approvals 2020
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands…
Switzerland: A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
Read more: Switzerland >>
Focus on Singapore
APAC: Prestige & HH&L IPO News; Cold Chain Vaccine…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for…
Singapore: Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long…
Singapore Macroeconomic & Competitiveness Snapshot 2020
Singapore is far ahead of its Asia-Pacific peers in terms of GDP per person.…
HSA: APAC’s Regulatory Gold Standard
As the most important pharma hub in its region, and one of the most important…
Read more: Singapore >>
Focus on Europe
Latvia: Striving to Catch Up to its Neighbours on Innovation…
Dr Valters Bolevics, director general of the Association of International…
Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that…
Europe: EMA Medicine Approvals 2020
The full list of medicines recommended for approval by the European Medicines…
Can Europe’s Beating Cancer Plan Make it an Innovation…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating…
Read more: Europe >>
Focus on Vaccines
Italy Pharma News: Mandatory COVID-19 Vaccines for…
The latest from Italian pharma, including the government’s decision to make…
LatAm Pharma News: COVAX Rollout in Colombia; União Quimica…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia,…
Novavax: From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
Russia Pharma News: Biocad Ramps up Sputnik V Manufacturing;…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik…
Read more: Vaccines >>
Focus on MEA
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…
MEA Roundup: Turkey’s Pharma Debt; Saudi Market Rise; UAE…
A roundup of the latest from the Middle East & Africa region, including…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…